These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23259025)

  • 1. Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4).
    Gauthier S; Patterson C; Chertkow H; Gordon M; Herrmann N; Rockwood K; Rosa-Neto P; Soucy JP
    Can Geriatr J; 2012 Dec; 15(4):120-6. PubMed ID: 23259025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia.
    Ismail Z; Black SE; Camicioli R; Chertkow H; Herrmann N; Laforce R; Montero-Odasso M; Rockwood K; Rosa-Neto P; Seitz D; Sivananthan S; Smith EE; Soucy JP; Vedel I; Gauthier S;
    Alzheimers Dement; 2020 Aug; 16(8):1182-1195. PubMed ID: 32725777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.
    Rosa-Neto P; Hsiung GY; Masellis M;
    Alzheimers Res Ther; 2013 Nov; 5(Suppl 1):S8. PubMed ID: 24565514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.
    Herrmann N; Lanctôt KL; Hogan DB
    Alzheimers Res Ther; 2013 Jul; 5(Suppl 1):S5. PubMed ID: 24565367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Jack CR; Albert MS; Knopman DS; McKhann GM; Sperling RA; Carrillo MC; Thies B; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):257-62. PubMed ID: 21514247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia.
    Chertkow H; Feldman HH; Jacova C; Massoud F
    Alzheimers Res Ther; 2013 Jul; 5(Suppl 1):S2. PubMed ID: 24565215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.
    Carrillo MC; Dean RA; Nicolas F; Miller DS; Berman R; Khachaturian Z; Bain LJ; Schindler R; Knopman D;
    Alzheimers Dement; 2013 Sep; 9(5):594-601. PubMed ID: 24007744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    McKhann GM; Knopman DS; Chertkow H; Hyman BT; Jack CR; Kawas CH; Klunk WE; Koroshetz WJ; Manly JJ; Mayeux R; Mohs RC; Morris JC; Rossor MN; Scheltens P; Carrillo MC; Thies B; Weintraub S; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):263-9. PubMed ID: 21514250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological markers and Alzheimer disease: a canadian perspective.
    Schipper HM
    Int J Alzheimers Dis; 2010 Aug; 2010():. PubMed ID: 20811568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of Alzheimer disease.
    Growdon JH
    Arch Neurol; 1999 Mar; 56(3):281-3. PubMed ID: 10190817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial.
    Rosenberg A; Solomon A; Soininen H; Visser PJ; Blennow K; Hartmann T; Kivipelto M;
    Alzheimers Res Ther; 2021 Mar; 13(1):64. PubMed ID: 33766132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
    Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5).
    Rockwood K; Andrew MK; Aubertin-Leheudre M; Belleville S; Bherer L; Bowles SK; Kehler DS; Lim A; Middleton L; Phillips N; Wallace LMK
    Alzheimers Dement (N Y); 2020; 6(1):e12083. PubMed ID: 33204818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Sperling RA; Aisen PS; Beckett LA; Bennett DA; Craft S; Fagan AM; Iwatsubo T; Jack CR; Kaye J; Montine TJ; Park DC; Reiman EM; Rowe CC; Siemers E; Stern Y; Yaffe K; Carrillo MC; Thies B; Morrison-Bogorad M; Wagster MV; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):280-92. PubMed ID: 21514248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria.
    Sperling R; Johnson K
    Continuum (Minneap Minn); 2013 Apr; 19(2 Dementia):325-38. PubMed ID: 23558480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of DSM-5 and IWG-2 criteria for the diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Baker KG
    Diagnosis (Berl); 2016 Mar; 3(1):9-12. PubMed ID: 29540044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.